News

Bora, a contract development and manufacturing organization (CDMO) which specializes in modified release and solvent production, has announced the appointment of Samuel Ricchezza as President of North America Operations. Bringing over 25 years’ CDMO experience to the team, Ricchezza is...

European speciality pharmaceutical company Neuraxpharm Group has announced the launch of Neuraxpharm Portugal as part of an expansion of its operations in Southern Europe. Neuraxpharm Portugal will be based in Lisbon and be part of the Southern European Region, which...

China’s National Healthcare Security Administration (NHSA) has announced it has agreed an average 61% cut in prices of 70 top-selling drugs with large pharma manufacturers in exchange for inclusion on a state-run insurance scheme list. According to the South China...

The US Food and Drug Administration (FDA) has granted tentative approval for Aleor Dermaceuticals’ Diclofenac sodium topical solution USP, 2% w / w to treat the pain of osteoarthritis of the knees. Aleor is a 60:40 joint venture (JV) between...

High Purity New England, a leading supplier of biotech equipment and process systems for the Biotech industry, has launched ClearMixx, an innovative single use mixing system. The latest addition to the growing High Purity New England product range, ClearMixx utilizes...

UK-based pharmaceutical company ImmuPharma has signed a licensing and development agreement with US-based Avion Pharmaceuticals for Lupuzor, a peptide therapeutic and a first-in-class autophagy immunomodulator for auto-immune disease systemic lupus erythematosus (SLE or lupus). Under the agreement, the two firms...

The global pharmaceutical company and service partner Inceptua Group (previously Multipharma GmbH) and Bendalis GmbH – German manufacturer of generic oncology drugs and special therapeutic agents, announce the signing of an exclusive clinical trial supply agreement for oncology generics. Through...